Health Condition 1: K402- Bilateral inguinal hernia, withoutobstruction or gangrene
Conditions
Interventions
Intervention1: Cefotaxime: Cefotaxime 1gm intravenous at the time of induction for group A patients,
Cefotaxime 1gm intravenous at the time of induction followed by Cefotaxime 1gm intravenous,BD for
Sponsors
Dr Samit Doshi
Eligibility
Inclusion criteria
Inclusion criteria: 1) All patients undergoing elective open inguinal mesh hernioplasty. 2) Patients with Unilateral inguinal hernia and Bilateral inguinal hernia. 3) Patients giving consent for taking part in the study. 4) Patients above 18 years of age. 5) All clean hernia surgeries.
Exclusion criteria
Exclusion criteria: 1) Patients below 18 years of age. 2) All the other hernias except inguinal hernias. 3) Patients on steroid treatment or patients with immunosuppressed states and malignancy. 4) Patients having local site infections like Tinea or Scabies. 5) All patients with complicated hernia such as Irreducible hernia, Obstructed hernia and Strangulated hernia. 6) All patients allergic to Cephalosporins. 7) All Laparoscopic hernia repairs. 8) All Recurrent inguinal hernias. 9) All clean-contaminated, contaminated and dirty hernia surgeries.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| From this study it is expected that 1) multiple dose Cefotaxime does not cause a significant decrease in the rate of surgical site infection compared to single dose Cefotaxime 2) Lower treatment costs for the patient and is cost effective 3) Reduce the spread of antibiotic resistance 4) Avoidance of side effects due to overuse of antibiotics 5) Reduce hospital stayTimepoint: Assessment of patients to evaluate surgical site infection on day 3 day 5 day 7 day 15 and day 30 | — |
Secondary
| Measure | Time frame |
|---|---|
| noneTimepoint: none | — |
Countries
India
Contacts
Public ContactDr Samit Doshi
MGM Institute of Health Sciences Navi Mumbai
Outcome results
None listed